0001209191-11-045977.txt : 20110830
0001209191-11-045977.hdr.sgml : 20110830
20110830154426
ACCESSION NUMBER: 0001209191-11-045977
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110829
FILED AS OF DATE: 20110830
DATE AS OF CHANGE: 20110830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 111065806
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-08-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2011-08-29
4
M
0
4300
10.41
A
138035
D
Common Stock
2011-08-29
4
M
0
5200
11.27
A
143235
D
Common Stock
2011-08-29
4
S
0
9500
45.01
D
133735
D
Common Stock
4495
I
401(k)
Stock Options
10.41
2011-08-29
4
M
0
4300
0.00
D
2015-02-02
Common Stock
4300
0
D
Stock Options
11.27
2011-08-29
4
M
0
5200
0.00
D
2014-10-06
Common stock
5200
12800
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $45.01 (range $45.00 to $45.26).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Fully vested.
Kenneth S. Boger, Attorney-In-Fact
2011-08-30